WebJun 21, 2024 · Today, without knowledge of the clot’s characteristics, the clot can only be removed on the first attempt in one out of three cases. Clotild ® Smart Guidewire System integrating Sensome’s AI -powered … WebThe Clotild smart guidewire system (Sensome), which uses artificial intelligence (AI) to provide real-time insights on clot composition, is showing early promise in the first-in-human CLOT OUT study, according to Hal Rice (Gold Coast …

Sensome’s Clotild AI-Powered Stroke Guidewire Receives FDA …

WebJun 24, 2024 · The guidewire system uses an artificial intelligence-powered tissue sensor that gives physicians critical information about the clot that caused the patient’s stroke. The first-in-human clinical trial of the system is expected to start later this year, according to Sensome’s CEO Franz Bozsak. Devices Submissions and Approvals cleveland nonprofit boards

Sensome Receives FDA “Breakthrough Device Designation” for its …

WebSep 13, 2024 · Clotild®Smart Guidewire System integrating Sensome’s AI-powered tissue sensor enables the guidewire to provide physicians with critical information on the clot. “Endovascular thrombectomy is no longer just about removing the clot. WebJun 1, 2024 · In this conference, Hal Rice presents the preliminary results from the CLOT OUT study, demonstrating the safety and performance of the smart guidewire Clotild in … WebIts first application is the Clotild® connected guidewire for the treatment of ischemic stroke. Sensome's sensor technology can be deployed in multiple other medical fields, such as interventional cardiology and oncology. … bmd handbuch download